Cargando…
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631708/ https://www.ncbi.nlm.nih.gov/pubmed/35613463 http://dx.doi.org/10.1182/bloodadvances.2022007138 |
| _version_ | 1784823874251128832 |
|---|---|
| author | Scarfò, Lydia Ferrari, Silvia Frustaci, Anna Maria Tani, Monica Bari, Alessia Scarano, Eloise Colia, Maria Ranghetti, Pamela Angelillo, Piera Ronchi, Paola Ponzoni, Maurilio Ferreri, Andrés J. M. Ghia, Paolo |
| author_facet | Scarfò, Lydia Ferrari, Silvia Frustaci, Anna Maria Tani, Monica Bari, Alessia Scarano, Eloise Colia, Maria Ranghetti, Pamela Angelillo, Piera Ronchi, Paola Ponzoni, Maurilio Ferreri, Andrés J. M. Ghia, Paolo |
| author_sort | Scarfò, Lydia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9631708 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96317082022-11-04 Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial Scarfò, Lydia Ferrari, Silvia Frustaci, Anna Maria Tani, Monica Bari, Alessia Scarano, Eloise Colia, Maria Ranghetti, Pamela Angelillo, Piera Ronchi, Paola Ponzoni, Maurilio Ferreri, Andrés J. M. Ghia, Paolo Blood Adv Research Letter American Society of Hematology 2022-09-21 /pmc/articles/PMC9631708/ /pubmed/35613463 http://dx.doi.org/10.1182/bloodadvances.2022007138 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Scarfò, Lydia Ferrari, Silvia Frustaci, Anna Maria Tani, Monica Bari, Alessia Scarano, Eloise Colia, Maria Ranghetti, Pamela Angelillo, Piera Ronchi, Paola Ponzoni, Maurilio Ferreri, Andrés J. M. Ghia, Paolo Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title | Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title_full | Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title_fullStr | Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title_full_unstemmed | Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title_short | Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial |
| title_sort | anti-cd20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the more trial |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631708/ https://www.ncbi.nlm.nih.gov/pubmed/35613463 http://dx.doi.org/10.1182/bloodadvances.2022007138 |
| work_keys_str_mv | AT scarfolydia anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ferrarisilvia anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT frustaciannamaria anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT tanimonica anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT barialessia anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT scaranoeloise anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT coliamaria anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ranghettipamela anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT angelillopiera anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ronchipaola anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ponzonimaurilio anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ferreriandresjm anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial AT ghiapaolo anticd20rechallengewithofatumumabinrelapsedrefractorysplenicmarginalzonelymphomathemoretrial |